1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow olpasiran: new trials by email Literature Review of olpasiran trials Research Report on olpasiran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study Olpasiran, Placebo - Cardiovascular Disease | Phase 2 | Completed | Amgen | 281 | 2020-07-28 | 2026-03-31 |
Atherosclerosis (1) · Cardiovascular Diseases (1) · Dyslipidemias (1) · Hyperlipidemias (1)
Amgen (1)
Australia (1) · Canada (1) · Denmark (1) · Iceland (1) · Japan (1) · Netherlands (1) · United States (1)
2019 (1)